Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer’s-like changes

Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action

Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · see citing works

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · see citing works

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

Coyle, J. T., Price, D. L., & DeLong, M. R. (1983) · Science · doi:10.1126/science.6338589 · Cited by 3,050 · see citing works

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703 · see citing works

The GSK3 hypothesis of Alzheimer’s disease

Hooper, C., Killick, R., & Lovestone, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05194.x · Cited by 1,191 · see citing works

Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding

Bramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903 · see citing works

Amyloid β-peptide (1-42)-induced Oxidative Stress and Neurotoxicity: Implications for Neurodegeneration in Alzheimer's Disease Brain. A Review

Allan Butterfield, D. (2002) · Free Radical Research · doi:10.1080/1071576021000049890 · Cited by 786 · see citing works

Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides

Marambaud, P., Zhao, H., & Davies, P. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508246200 · Cited by 750 · see citing works

Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease

Frölich, L., Blum-Degen, D., Bernstein, H.-G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A., Türk, A., Hoyer, S., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050068 · Cited by 748 · see citing works

Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer’s disease: Link to brain reductions in acetylcholine

Rivera, E. J., Goldin, A., Fulmer, N., Tavares, R., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8304 · Cited by 723 · see citing works

Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: An update

Soldani, C., & Scovassi, A. I. (2002) · APOPTOSIS · doi:10.1023/a:1016119328968 · Cited by 697 · see citing works

Hyperinsulinemia and risk of Alzheimer disease

Luchsinger, J. A., Tang, M.-X., Shea, S., & Mayeux, R. (2004) · Neurology · doi:10.1212/01.wnl.0000140292.04932.87 · Cited by 683 · see citing works

Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers

De Felice, F. G., Vieira, M. N. N., Bomfim, T. R., Decker, H., Velasco, P. T., Lambert, M. P., Viola, K. L., Zhao, W.-Q., Ferreira, S. T., & Klein, W. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809158106 · Cited by 657 · see citing works

AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-β Peptide Metabolism

Vingtdeux, V., Giliberto, L., Zhao, H., Chandakkar, P., Wu, Q., Simon, J. E., Janle, E. M., Lobo, J., Ferruzzi, M. G., Davies, P. J., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.060061 · Cited by 648 · see citing works

The role of insulin receptor signaling in the brain

Plum, L., Schubert, M., & Brüning, J. C. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.01.008 · Cited by 604 · see citing works

Amyloid beta oligomers induce impairment of neuronal insulin receptors

Zhao, W., De Felice, F. G., Fernandez, S., Chen, H., Lambert, M. P., Quon, M. J., Krafft, G. A., & Klein, W. L. (2008) · The FASEB Journal · doi:10.1096/fj.06-7703com · Cited by 587 · see citing works

Proline-directed and non-proline-directed phosphorylation of PHF-tau

Morishima-Kawashima, M., Hasegawa, M., Takio, K., Suzuki, M., Yoshida, H., Titani, K., & Ihara, Y. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.823 · Cited by 557 · see citing works

Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: Relevance to Alzheimer's disease

de la Monte, S. M., & Wands, J. R. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-7106 · Cited by 552 · see citing works

Role of insulin and insulin receptor in learning and memory

Zhao, W., & Alkon, D. L. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00455-5 · Cited by 492 · see citing works

Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells

Lovestone, S., Reynolds, C. H., Latimer, D. A., Davis, D. R., Anderton, B. H., Gallo, J., Hanger, D. P., Mulot, S., Marquardt, B., Stabel, S., et al. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00246-3 · Cited by 470 · see citing works

Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer’s disease

Lester-Coll, N., Rivera, E. J., Soscia, S. J., Doiron, K., Wands, J. R., & de la Monte, S. M. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9102 · Cited by 467 · see citing works

Insulin signaling in the central nervous system: Learning to survive

van der Heide, L. P., Ramakers, G. M. J., & Smidt, M. P. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.06.003 · Cited by 444 · see citing works

Antidiabetic drug metformin (Glucophage ^R ) increases biogenesis of Alzheimer's amyloid peptides via up-regulating <i>BACE1</i> transcription

Chen, Y., Zhou, K., Wang, R., Liu, Y., Kwak, Y.-D., Ma, T., Thompson, R. C., Zhao, Y., Smith, L., Gasparini, L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807991106 · Cited by 390 · see citing works

Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation.

Perry, G., Roder, H., Nunomura, A., Takeda, A., Friedlich, A., Zhu, X.-W., Raina, A., Holbrook, N., Siedlak, S., Harris, P., et al. (1999) · NeuroReport · doi:10.1097/00001756-199908020-00035 · Cited by 296 · see citing works

Maturation of neuroblastoma cells in the presence of dimethylsulfoxide.

Kimhi, Y., Palfrey, C., Spector, I., Barak, Y., & Littauer, U. Z. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.2.462 · Cited by 291 · see citing works

Lack of Neurodegeneration in Transgenic Mice Overexpressing Mutant Amyloid Precursor Protein Is Associated with Increased Levels of Transthyretin and the Activation of Cell Survival Pathways

Stein, T. D., & Johnson, J. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-17-07380.2002 · Cited by 288 · see citing works

Insulin increases CSF Aβ42 levels in normal older adults

Watson, G. S., Peskind, E. R., Asthana, S., Purganan, K., Wait, C., Chapman, D., Schwartz, M. W., Plymate, S. R., & Craft, S. (2003) · Neurology · doi:10.1212/01.wnl.0000065916.25128.25 · Cited by 265 · see citing works

Neuroprotective Role of Antidiabetic Drug Metformin Against Apoptotic Cell Death in Primary Cortical Neurons

El‐Mir, M., Détaille, D., R-Villanueva, G., Delgado‐Esteban, M., Guigas, B., Attia, S., Fontaine, E. M., Almeida, Á., & Leverve, X. M. (2007) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-9002-1 · Cited by 243 · see citing works

PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer's disease

Alkon, D. L., Sun, M., & Nelson, T. J. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.12.002 · Cited by 243 · see citing works

Structural Principles of Tau and the Paired Helical Filaments of Alzheimer's Disease

Mandelkow, E., Von Bergen, M., Biernat, J., & Mandelkow, E. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00053.x · Cited by 243 · see citing works

Rapid Tyrosine Phosphorylation of Neuronal Proteins Including Tau and Focal Adhesion Kinase in Response to Amyloid-β Peptide Exposure: Involvement of Src Family Protein Kinases

Williamson, R., Scales, T., Clark, B. R., Gibb, G., Reynolds, C. H., Kellie, S., Bird, I. N., Varndell, I. M., Sheppard, P. W., Everall, I., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00010.2002 · Cited by 227 · see citing works

Metformin therapy in a transgenic mouse model of Huntington's disease

Ma, T. C., Buescher, J. L., Oatis, B., Funk, J. A., Nash, A. J., Carrier, R. L., & Hoyt, K. R. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.10.039 · Cited by 220 · see citing works

Chronic activation of ERK and neurodegenerative diseases

Colucci‐D'Amato, L., Perrone‐Capano, C., & di Porzio, U. (2003) · BioEssays · doi:10.1002/bies.10355 · Cited by 195 · see citing works

Brain glucose transporters, O‐GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer’s disease

Liu, Y. M., Liu, F., Grundke, I., Iqbal, K., & Gong, C. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06320.x · Cited by 193 · see citing works

Signaling Events in Amyloid β-Peptide-induced Neuronal Death and Insulin-like Growth Factor I Protection

Wei, W., Wang, X., & Kusiak, J. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111704200 · Cited by 190 · see citing works

Causes and Consequences of Disturbances of Cerebral Glucose Metabolism in Sporadic Alzheimer Disease: Therapeutic Implications

Hoyer, S. (2004) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-8969-7_8 · Cited by 173 · see citing works

ERK activation promotes neuronal degeneration predominantly through plasma membrane damage and independently of caspase-3

Subramaniam, S., Zirrgiebel, U., Halbach, O. V. B. U., Strelau, J., Laliberté, C. L., Kaplan, D. R., & Unsicker, K. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403028 · Cited by 150 · see citing works

Comparative Analysis of an Improved Thioflavin-S Stain, Gallyas Silver Stain, and Immunohistochemistry for Neurofibrillary Tangle Demonstration on the Same Sections

Sun, A.-Y., Nguyen, X. V., & Bing, G. (2002) · Journal of Histochemistry and Cytochemistry · doi:10.1177/002215540205000403 · Cited by 146 · see citing works

Chronic gestational exposure to ethanol impairs insulin-stimulated survival and mitochondrial function in cerebellar neurons

de la Monte, S. M., & Wands, J. R. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8475-x · Cited by 123 · see citing works

N-methyl-d-aspartate (NMDA) and the regulation of mitogen-activated protein kinase (MAPK) signaling pathways: A revolving neurochemical axis for therapeutic intervention?

Haddad, J. J. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.10.008 · Cited by 121 · see citing works

Aberrant Activation of Focal Adhesion Proteins Mediates Fibrillar Amyloid β-Induced Neuronal Dystrophy

Grace, E. A., & Busciglio, J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-02-00493.2003 · Cited by 113 · see citing works

Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration?

Scheele, C., Nielsen, A. R., Walden, T. B., Sewell, D. A., Fischer, C. P., Brogan, R. J., Petrovic, N., Larsson, O., Tesch, P. A., Wennmalm, K., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8520com · Cited by 110 · see citing works

Metformin Protects the Brain Against the Oxidative Imbalance Promoted by Type 2 Diabetes

Correia, S. C., Carvalho, C., Santos, M. S., Proenca, T., Nunes, E., Duarte, A. I., Monteiro, P. F., Seiça, R. M. F., Oliveira, C. R., & Moreira, P. I. (2008) · Medicinal Chemistry · doi:10.2174/157340608784872299 · Cited by 110 · see citing works

Focal adhesions regulate Aβ signaling and cell death in Alzheimer's disease

Caltagarone, J., Jing, Z., & Bowser, R. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.11.007 · Cited by 102 · see citing works

Brain Insulin Impairs Amyloid-β(1-40) Clearance from the Brain

Shiiki, T., Ohtsuki, S., Kurihara, A., Naganuma, H., Nishimura, K., Tachikawa, M., Hosoya, K., & Terasaki, T. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2236-04.2004 · Cited by 101 · see citing works

Focal adhesion kinase expressed by nerve cell lines shows increased tyrosine phosphorylation in response to Alzheimer's A beta peptide.

Zhang, C., Lambert, M. P., Bunch, C., Barber, K., Wade, W. S., Krafft, G. A., & Klein, W. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47238-9 · Cited by 97 · see citing works

Central Insulin Signaling Is Attenuated by Long-Term Insulin Exposure via Insulin Receptor Substrate-1 Serine Phosphorylation, Proteasomal Degradation, and Lysosomal Insulin Receptor Degradation

Mayer, C., & Belsham, D. D. (2009) · Endocrinology · doi:10.1210/en.2009-0838 · Cited by 85 · see citing works

Endogenous insulin signaling protects cultured neurons from oxygen–glucose deprivation-induced cell death

Mielke, J. G., Taghibiglou, C., & Wang, Y. T. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.07.055 · Cited by 81 · see citing works

Development of insulin resistance and reversal by thiazolidinediones in C2C12 skeletal muscle cells

Kumar, N., & Dey, C. S. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01509-5 · Cited by 75 · see citing works

Focal adhesion kinase regulates insulin resistance in skeletal muscle

Bisht, B., Goel, H. L., & Dey, C. S. (2007) · Diabetologia · doi:10.1007/s00125-007-0591-6 · Cited by 63 · see citing works

Long-term abnormalities in brain glucose/energy metabolism after inhibition of the neuronal insulin receptor: implication of tau-protein

Hoyer, S., & Lannert, H. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_25 · Cited by 59 · see citing works

Receptor and postreceptor insulin resistance induced by in vivo hyperinsuiinemia

Martin, C., DESAI, K. S., & Steiner, G. A. (1983) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y83-123 · Cited by 47 · see citing works

5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) attenuates the expression of LPS- and Aβ peptide-induced inflammatory mediators in astroglia

Ayasolla, K., Giri, S., Singh, A. K., & Singh, I. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-21 · Cited by 45 · see citing works

Models of Alzheimer’s disease: cellular and molecular aspects

Hoyer, S. (1997) · Springer eBooks · doi:10.1007/978-3-7091-6844-8_2 · Cited by 43 · see citing works

Metformin Normalizes Type 2 Diabetes-Induced Decrease in Cell Proliferation and Neuroblast Differentiation in the Rat Dentate Gyrus

Hwang, I. K., Kim, I. Y., Joo, E. J., Shin, J. H., Choi, J. W., Won, M., Yoon, Y. S., & Seong, J. K. (2010) · Neurochemical Research · doi:10.1007/s11064-009-0115-5 · Cited by 43 · see citing works

Antisense inhibition at the β-secretase-site of β-amyloid precursor protein reduces cerebral amyloid and acetyl cholinesterase activity in Tg2576

Chauhan, N. B., & Siegel, G. J. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.01.008 · Cited by 40 · see citing works

Insulin inhibits extracellular regulated kinase 1/2 phosphorylation in a phosphatidylinositol 3‐kinase (PI3) kinase‐dependent manner in Neuro2a cells

van der Heide, L. P., Hoekman, M. F. M., Biessels, G. J., & Gispen, W. H. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01828.x · Cited by 36 · see citing works

Estimating and disclosing the risk of developing Alzheimer‘s disease: challenges, controversies and future directions

Roberts, J. S., & Tersegno, S. M. (2010) · Future Neurology · doi:10.2217/fnl.10.31 · Cited by 31 · see citing works

Long-term effect of insulin on glucose transport and insulin binding in cultured adipocytes from normal and obese humans with and without non-insulin-dependent diabetes.

Sinha, M. K., Taylor, L. G., Pories, W. J., Flickinger, E. G., Meelheim, D., Atkinson, S. A., Sehgal, N. S., & Caro, J. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113163 · Cited by 26 · see citing works

Involvement of Elk‐1 in L6E9 skeletal muscle differentiation

Khurana, A., & Dey, C. S. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03192-7 · Cited by 19 · see citing works

Untitled work

Nilsson (1999) · doi:10.1002/(sici)1097-4695(19990615)39:4

Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

Talbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871 · see citing works

Metformin: An Old But Still the Best Treatment for Type 2 Diabetes

Rojas, L. B. A., & Gomes, M. B. (2013) · Diabetology &amp; Metabolic Syndrome · doi:10.1186/1758-5996-5-6 · Cited by 567 · see citing works

Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain

Butterfield, D. A., Di Domenico, F., & Barone, E. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.010 · Cited by 402 · see citing works

Metformin, Other Antidiabetic Drugs, and Risk of Alzheimer's Disease: A Population‐Based Case–Control Study

Imfeld, P., Bodmer, M., Jick, S. S., & Meier, C. R. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03916.x · Cited by 389 · see citing works

Effects of the Insulin Sensitizer Metformin in Alzheimer Disease

Koenig, A. M., Mechanic-Hamilton, D. J., Xie, S. X., Combs, M., Cappola, A. R., Xie, L., Detre, J. A., Wolk, D. A., & Arnold, S. E. (2017) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000202 · Cited by 352 · see citing works

Insulin resistance and Parkinson’s disease: A new target for disease modification?

Athauda, D. S., & Foltynie, T. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.10.001 · Cited by 333 · see citing works

High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice

Arnold, S. E., Lucki, I., Brookshire, B. R., Carlson, G. C., Browne, C. A., Kazi, H., Bang, S., Choi, B., Chen, Y., McMullen, M. F., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.03.011 · Cited by 315 · see citing works

The Therapeutic Potential of Metformin in Neurodegenerative Diseases

Rotermund, C., Machetanz, G., & Fitzgerald, J. C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00400 · Cited by 310 · see citing works

Drug repositioning for Alzheimer's disease

Corbett, A., Pickett, J., Burns, A. S., Corcoran, J. P. T., Dunnett, S. B., Edison, P., Hagan, J. J., Holmes, C., Jones, E., Katona, C., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3869 · Cited by 302 · see citing works

Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial

Luchsinger, J. A., Perez, T., Chang, H., Mehta, P., Steffener, J., Pradabhan, G., Ichise, M., Manly, J., Devanand, D. P., & Bagiella, E. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150493 · Cited by 285 · see citing works

Insulin signaling pathway and related molecules: Role in neurodegeneration and Alzheimer's disease

Akhtar, A., & Sah, S. P. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104707 · Cited by 286 · see citing works

The role of type 2 diabetes in neurodegeneration

Verdile, G., Fuller, S. J., & Martins, R. N. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.008 · Cited by 276 · see citing works

Metformin: Is it a drug for all reasons and diseases?

Triggle, C. R., Mohammed, I., Bshesh, K., Marei, I., Ye, K., Ding, H., MacDonald, R. S., Hollenberg, M. D., & Hill, M. A. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155223 · Cited by 282 · see citing works

Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases

Gomes, M. B., & Negrato, C. A. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-80 · Cited by 273 · see citing works

Diabetes Mellitus and the Risk of Alzheimer’s Disease: A Nationwide Population-Based Study

Huang, C., Chung, C., Leu, H., Lin, L., Chiu, C.-C., Hsu, C., Chiang, C.-H., Huang, P., Chen, T., Lin, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087095 · Cited by 266 · see citing works

Metformin attenuates Alzheimer’s disease-like neuropathology in obese, leptin-resistant mice

Li, J., Deng, J., Sheng, W., & Zuo, Z. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.03.002 · Cited by 260 · see citing works

Metformin – a Future Therapy for Neurodegenerative Diseases

Markowicz-Piasecka, M., Sikora, J., Szydłowska, A., Skupień, A., Mikiciuk-Olasik, E., & Huttunen, K. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2199-y · Cited by 248 · see citing works

Type 2 Diabetes Mellitus and Alzheimer’s Disease: Role of Insulin Signalling and Therapeutic Implications

Tumminia, A., Vinciguerra, F., Parisi, M., & Frittitta, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113306 · Cited by 252 · see citing works

The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review

Reich, N., & Hölscher, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.970925 · Cited by 248 · see citing works

A Brief Overview of Tauopathy: Causes, Consequences, and Therapeutic Strategies

Orr, M. E., Sullivan, A. C., & Frost, B. E. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.03.011 · Cited by 232 · see citing works

Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease

Yarchoan, M. M., & Arnold, S. E. (2014) · Diabetes · doi:10.2337/db14-0287 · Cited by 228 · see citing works

Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study

Samaras, K., Makkar, S. R., Crawford, J. D., Kochan, N. A., Wen, W. X., Draper, B., Trollor, J. N., Brodaty, H., & Sachdev, P. S. (2020) · Diabetes Care · doi:10.2337/dc20-0892 · Cited by 228 · see citing works

Copper signalling: causes and consequences

Kardos, J., Héja, L., Simon, Á., Jablonkai, I., Kovács, R., & Jemnitz, K. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0277-3 · Cited by 214 · see citing works

Type 2 diabetes as a redox disease

Watson, J. D. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62365-x · Cited by 203 · see citing works

Roles of AMP-activated Protein Kinase in Alzheimer’s Disease

Cai, Z., Yan, L., Li, K., Quazi, S. H., & Zhao, B. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8173-2 · Cited by 191 · see citing works

Antidiabetic agents as a novel treatment for Alzheimer’s and Parkinson’s disease

Nowell, J., Blunt, E., Gupta, D., & Edison, P. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101979 · Cited by 179 · see citing works

Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer’s disease

Rad, S. K., Arya, A., Karimian, H., Madhavan, P., Rizwan, F., Koshy, S., & Prabhu, G. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s173970 · Cited by 155 · see citing works

Diabetes drugs and neurological disorders: new views and therapeutic possibilities

Patrone, C., Eriksson, O., & Lindholm, D. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70125-6 · Cited by 154 · see citing works

Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus

Shi, Q., Liu, S., Fonseca, V. A., Thethi, T. K., & Shi, L. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024954 · Cited by 144 · see citing works

Metformin and ageing: improving ageing outcomes beyond glycaemic control

Valencia, W. M., Palacio, A., Tamariz, L., & Florez, H. (2017) · Diabetologia · doi:10.1007/s00125-017-4349-5 · Cited by 142 · see citing works

Diabetes drugs in the fight against Alzheimer's disease

Boccardi, V., Murasecco, I., & Mecocci, P. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100936 · Cited by 142 · see citing works

G lycation in P arkinson's disease and Alzheimer's disease

Miranda, H. V., El‐Agnaf, O. M. A., & Outeiro, T. F. (2016) · Movement Disorders · doi:10.1002/mds.26566 · Cited by 142 · see citing works

Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism

Ott, V., Benedict, C., Schultes, B., Born, J., & Hallschmid, M. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01490.x · Cited by 139 · see citing works

Metformin: A Novel Weapon Against Inflammation

Bai, B., & Chen, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.622262 · Cited by 139 · see citing works

Differential effects of metformin on age related comorbidities in older men with type 2 diabetes

Wang, C.-P., Lorenzo, C., Habib, S. L., Jo, B., & Espinoza, S. E. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.01.013 · Cited by 134 · see citing works

Antidiabetic drugs restore abnormal transport of amyloid-β across the blood–brain barrier and memory impairment in db/db mice

Chen, F., Dong, R. R., Zhong, K. L., Ghosh, A., Tang, S. S., Long, Y., Hu, M. Y., Miao, M. X., Liao, J. M., Sun, H. B., et al. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.07.023 · Cited by 137 · see citing works

Association of metformin administration with gut microbiome dysbiosis in healthy volunteers

Elbere, I., Kalniņa, I., Silamiķelis, I., Konrāde, I., Zaharenko, L., Sekace, K., Radoviča-Spalviņa, I., Frīdmanis, D., Gudrā, D., Pīrāgs, V., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204317 · Cited by 134 · see citing works

Link between Diabetes and Alzheimer’s Disease Due to the Shared Amyloid Aggregation and Deposition Involving Both Neurodegenerative Changes and Neurovascular Damages

Stanciu, G. D., Bild, V., Ababei, D. C., Rusu, R.-N., Cobzaru, A., Păduraru, L., & Bulea, D. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061713 · Cited by 126 · see citing works

Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy

Barini, E., Antico, O., Zhao, Y., Asta, F., Tucci, V., Catelani, T., Marotta, R., Xu, H., & Gasparini, L. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0082-7 · Cited by 126 · see citing works

Metformin activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against Amyloid-beta-induced mitochondrial dysfunction

Chiang, M., Cheng, Y., Chen, S., Yen, C., & Huang, R. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.08.013 · Cited by 123 · see citing works

Insulin resistance in Alzheimer's disease

Dineley, K. T., Jahrling, J. B., & Denner, L. A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.09.001 · Cited by 124 · see citing works

PTEN, a widely known negative regulator of insulin/PI3K signaling, positively regulates neuronal insulin resistance

Gupta, A. K., & Dey, C. S. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-05-0337 · Cited by 119 · see citing works

AMPK: A bridge between diabetes mellitus and Alzheimer's disease

Chen, M., Huang, N., Liu, J., Huang, J., Shi, J., & Jin, F. J. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113043 · Cited by 118 · see citing works

Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders

Tabarés‐Seisdedos, R., & Rubenstein, J. L. R. (2013) · Nature reviews. Neuroscience · doi:10.1038/nrn3464 · Cited by 114 · see citing works

Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression

Kashani, L., Omidvar, T., Farazmand, B., Modabbernia, A., Ramzanzadeh, F., Tehraninejad, E. S., Ashrafi, M., Tabrizi, M., & Akhondzadeh, S. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.08.010 · Cited by 116 · see citing works

Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer’s disease: Pooled analysis from 5 cohorts

Weinstein, G., Davis‐Plourde, K. L., Conner, S. C., Himali, J. J., Beiser, A., Lee, A., Rawlings, A. M., Sedaghat, S., Ding, J., Moshier, E. L., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212293 · Cited by 115 · see citing works

Modulation of Mitochondrial Complex I Activity Averts Cognitive Decline in Multiple Animal Models of Familial Alzheimer's Disease

Zhang, L., Zhang, S., Maezawa, I., Trushin, S., Minhas, P. S., Pinto, M., Jin, L., Prasain, K., Nguyen, T. D. T., Yamazaki, Y., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.03.009 · Cited by 110 · see citing works

Metformin Treatment Alters Memory Function in a Mouse Model of Alzheimer's Disease

DiTacchio, K. A., Heinemann, S. F., & Dziewczapolski, G. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141332 · Cited by 110 · see citing works

Metformin loaded phosphatidylserine nanoliposomes improve memory deficit and reduce neuroinflammation in streptozotocin-induced Alzheimer's disease model

Saffari, P. M., Alijanpour, S., Takzaree, N., Sahebgharani, M., Etemad‐Moghadam, S., Noorbakhsh, F., & Partoazar, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117861 · Cited by 104 · see citing works

Differential metformin dose-dependent effects on cognition in rats: role of Akt

Mostafa, D. K., Ismail, C. A., & Ghareeb, D. A. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4301-2 · Cited by 101 · see citing works

BACE1: More than just a β‐secretase

Taylor, H. A., Przemyłska, L., Clavane, E. M., & Meakin, P. J. (2022) · Obesity Reviews · doi:10.1111/obr.13430 · Cited by 102 · see citing works

Metformin role in Parkinson’s disease: a double-sword effect

Alrouji, M., Al-Kuraishy, H. M., Al-Gareeb, A. I., Ashour, N. A., Jabir, M. S., Negm, W. A., & Batiha, G. E. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04771-7 · Cited by 104 · see citing works

Investigation of thymol effect on learning and memory impairment induced by intrahippocampal injection of amyloid beta peptide in high fat diet- fed rats

Asadbegi, M., Yaghmaei, P., Salehi, I., Komaki‬, A., & Ebrahim‐Habibi, A. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-9960-0 · Cited by 100 · see citing works

Lipid metabolism and neuroinflammation in Alzheimer’s disease: a role for liver X receptors

Kang, J., & Rivest, S. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1049 · Cited by 94 · see citing works

Role of insulin receptor substance-1 modulating PI3K/Akt insulin signaling pathway in Alzheimer’s disease

Zheng, M., & Wang, P. (2021) · 3 Biotech · doi:10.1007/s13205-021-02738-3 · Cited by 98 · see citing works

Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease – How Anti-Diabetics Could be a Solution for Dementia

Sebastião, I., Candeias, E., Santos, M. S., Oliveira, C. R., Moreira, P. I., & Duarte, A. I. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00110 · Cited by 92 · see citing works

Berberine Ameliorates Diabetes-Associated Cognitive Decline through Modulation of Aberrant Inflammation Response and Insulin Signaling Pathway in DM Rats

Chen, Q., Mo, R., Wu, N., Zou, X., Shi, C., Gong, J., Li, J., Fang, K., Wang, D., De-shen, Y., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00334 · Cited by 91 · see citing works

A Review: Treatment of Alzheimer’s Disease Discovered in Repurposed Agents

Appleby, B. S., Nacopoulos, D. A., Milano, N. J., Zhong, K., & Cummings, J. L. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000345791 · Cited by 90 · see citing works

Lycopene attenuates insulin signaling deficits, oxidative stress, neuroinflammation, and cognitive impairment in fructose-drinking insulin resistant rats

Yin, Q., Ma, Y., Yan, H., Hou, X., Chen, J., Shen, C., Sun, M., Shang, Y., Dong, S., Zeng, Z., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.07.020 · Cited by 90 · see citing works

The Anti-Diabetic Drug Metformin Reduces BACE1 Protein Level by Interfering with the MID1 Complex

Hettich, M. M., Matthes, F., Ryan, D. P., Griesche, N., Schröder, S., Dorn, S., Krauß, S., & Ehninger, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102420 · Cited by 90 · see citing works

Agmatine ameliorates type 2 diabetes induced-Alzheimer's disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling

Kang, S., Kim, C. H., Jung, H., Kim, E., Song, H., & Lee, J. E. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.10.029 · Cited by 89 · see citing works

A reappraisal on metformin

Adak, T., Samadi, A., Ünal, A. Z., & Sabuncuoğlu, S. (2017) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2017.12.023 · Cited by 88 · see citing works

Neuroprotective effects of metformin against Aβ-mediated inhibition of long-term potentiation in rats fed a high-fat diet

Asadbegi, M., Yaghmaei, P., Salehi, I., Ebrahim‐Habibi, A., & Komaki‬, A. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.02.005 · Cited by 87 · see citing works

Brain-specific repression of AMPKα1 alleviates pathophysiology in Alzheimer’s model mice

Zimmermann, H. R., Yang, W., Kasica, N. P., Zhou, X., Wang, X., Beckelman, B. C., Lee, J., Furdui, C. M., Keene, C. D., & Ma, T. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133982 · Cited by 86 · see citing works

Deciphering the Roles of Metformin in Alzheimer’s Disease: A Snapshot

Liao, W., Xu, J., Li, B., Ruan, Y., Li, T., & Liu, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.728315 · Cited by 84 · see citing works

Drug Repositioning Approaches for the Discovery of New Therapeutics for Alzheimer's Disease

Kim, T. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0325-7 · Cited by 82 · see citing works

Sweet but Bitter: Focus on Fructose Impact on Brain Function in Rodent Models

Spagnuolo, M. S., Iossa, S., & Cigliano, L. (2020) · Nutrients · doi:10.3390/nu13010001 · Cited by 83 · see citing works

Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutide

Candeias, E. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i6.807 · Cited by 83 · see citing works

Overlapped Metabolic and Therapeutic Links between Alzheimer and Diabetes

Ahmad, W. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8352-z · Cited by 80 · see citing works

Discovering New Treatments for Alzheimer's Disease by Repurposing Approved Medications

Appleby, B. S., & Cummings, J. L. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113136660162 · Cited by 78 · see citing works

Antioxidant and anti-senescence effect of metformin on mouse olfactory ensheathing cells (mOECs) may be associated with increased brain-derived neurotrophic factor levels-an ex vivo study

Śmieszek, A., Stręk, Z., Kornicka, K., Grzesiak, J., Weiss, C., & Marycz, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040872 · Cited by 77 · see citing works

Long-term use of metformin and Alzheimer’s disease: beneficial or detrimental effects

Al-Kuraishy, H. M., Al-Gareeb, A. I., Saad, ‏. M., & Batiha, G. E. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01163-7 · Cited by 78 · see citing works

Alterations in Glucose Metabolism on Cognition: A Possible Link Between Diabetes and Dementia

González-Reyes, R. E., Aliev, G. M., Ávila-Rodriguez, M., & Barreto, G. E. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666151209152013 · Cited by 77 · see citing works

True or false? Alzheimer’s disease is type 3 diabetes: Evidences from bench to bedside

Peng, Y., Yao, S.-Y., Chen, Q., Jin, H., Du, M., Xue, Y.-H., & Liu, S. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102383 · Cited by 76 · see citing works

Metformin treatment ameliorates diabetes‐associated decline in hippocampal neurogenesis and memory via phosphorylation of insulin receptor substrate 1

Tanokashira, D., Kurata, E., Fukuokaya, W., Kawabe, K., Mana, K., Takeuchi, H., Nakazato, M., & Taguchi, A. (2018) · FEBS Open Bio · doi:10.1002/2211-5463.12436 · Cited by 76 · see citing works

The Bewildering Effect of AMPK Activators in Alzheimer’s Disease: Review of the Current Evidence

Assefa, B. T., Tafere, G. G., Wondafrash, D. Z., & Gidey, M. T. (2020) · BioMed Research International · doi:10.1155/2020/9895121 · Cited by 75 · see citing works

Metformin, lifestyle intervention, and cognition in the Diabetes Prevention Program Outcomes Study

Luchsinger, J. A., Ma, Y., Christophi, C. A., Florez, H., Golden, S. H., Hazuda, H., Crandall, J., Venditti, E., Watson, K., Jeffries, S., et al. (2017) · Diabetes Care · doi:10.2337/dc16-2376 · Cited by 75 · see citing works

A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug?

Maniar, K., Moideen, A., Mittal, A., Patil, A., Chakrabarti, A., & Banerjee, D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.003 · Cited by 75 · see citing works

Altered APP Processing in Insulin-Resistant Conditions Is Mediated by Autophagosome Accumulation via the Inhibition of Mammalian Target of Rapamycin Pathway

Son, S., Song, H., Byun, J., Park, K., Jang, H., Park, Y., & Mook-Jung, I. (2012) · Diabetes · doi:10.2337/db11-1735 · Cited by 74 · see citing works

Neuronal stress signaling and eIF2α phosphorylation as molecular links between Alzheimer's disease and diabetes

Lourenco, M. V., Ferreira, S. T., & Felice, F. G. D. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.03.003 · Cited by 71 · see citing works

Cinnamon Counteracts the Negative Effects of a High Fat/High Fructose Diet on Behavior, Brain Insulin Signaling and Alzheimer-Associated Changes

Anderson, R. A., Qin, B., Canini, F., Poulet, L., & Roussel, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083243 · Cited by 71 · see citing works

Therapeutic Potential of AMP-Activated Protein Kinase in Alzheimer’s Disease

Wang, X., Zimmermann, H. R., & Ma, T. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181043 · Cited by 69 · see citing works

Association of metformin use with Alzheimer’s disease in patients with newly diagnosed type 2 diabetes: a population-based nested case–control study

Ha, J.-H., Choi, D., Kim, K. J., Cho, S. Y., Kim, H., Kim, K. Y., Koh, Y., Nam, C. M., & Kim, E. (2021) · Scientific Reports · doi:10.1038/s41598-021-03406-5 · Cited by 64 · see citing works

Metformin raises hydrogen sulfide tissue concentrations in various mouse organs

Wiliński, B., Wiliński, J., Somogyi, E., Piotrowska, J., & Opoka, W. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71053-3 · Cited by 67 · see citing works

Metformin, Cognitive Function, and Changes in the Gut Microbiome

Rosell-Díaz, M., & Fernández‐Real, J. M. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad029 · Cited by 68 · see citing works

Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity

Jantrapirom, S., Nimlamool, W., Chattipakorn, N., Chattipakorn, S. C., Temviriyanukul, P., Inthachat, W., Govitrapong, P., & Potikanond, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051725 · Cited by 63 · see citing works

AKT ISOFORMS-AS160-GLUT4: The defining axis of insulin resistance

Sharma, M., & Dey, C. S. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09652-2 · Cited by 66 · see citing works

Evidence for altered insulin receptor signaling in Alzheimer's disease

Griffith, C. M., Eid, T., Rose, G. M., & Patrylo, P. R. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.008 · Cited by 61 · see citing works

Effects of Diabetes Mellitus on Cognitive Decline in Patients with Alzheimer Disease: A Systematic Review

Li, J., Cesari, M., Liu, F., Dong, B., & Vellas, B. J. (2016) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.07.003 · Cited by 60 · see citing works

Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes

Palleria, C., Leporini, C., Maida, F., Succurro, E., Sarro, G. D., Arturi, F., & Russo, E. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.07.002 · Cited by 60 · see citing works

Repurposing metformin to treat age-related neurodegenerative disorders and ischemic stroke

Sharma, S., Nozohouri, S., Vaidya, B., & Abbruscato, T. J. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119343 · Cited by 60 · see citing works

Antidiabetic drugs for Alzheimer's and Parkinson's diseases: Repurposing insulin, metformin, and thiazolidinediones

(2020) · International Review of Neurobiology · doi:10.1016/bs.irn.2020.02.010 · Cited by 58 · see citing works

Alzheimer's Disease and Diabetes: New Insights and Unifying Therapies

Vignini, A., Giulietti, A., Nanetti, L., Raffaelli, F., Giusti, L., Mazzanti, L., & Provinciali, L. (2013) · Current Diabetes Reviews · doi:10.2174/1573399811309030003 · Cited by 57 · see citing works

Metformin Attenuates Aβ Pathology Mediated Through Levamisole Sensitive Nicotinic Acetylcholine Receptors in a C. elegans Model of Alzheimer’s Disease

Ahmad, W., & Ebert, P. R. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0085-y · Cited by 57 · see citing works

Adiponectin: The Potential Regulator and Therapeutic Target of Obesity and Alzheimer’s Disease

Kim, J. Y., Barua, S., Jeong, Y. J., & Lee, J. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176419 · Cited by 58 · see citing works

Type 2 diabetes and/or its treatment leads to less cognitive impairment in Alzheimer's disease patients

Domínguez, R. O., Marschoff, E. R., González, S., Repetto, M. G., & Serra, J. A. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.05.013 · Cited by 57 · see citing works

Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology

Huang, Y., Wang, X., Chen, Y., Li, C., Zhang, L., Zhang, L., Liang, E., Liu, T., & Mao, J. (2022) · Medicine · doi:10.1097/md.0000000000031437 · Cited by 56 · see citing works

Antidiabetic Drugs in Alzheimer’s Disease: Mechanisms of Action and Future Perspectives

Femminella, G. D., Bencivenga, L., Petraglia, L., Visaggi, L., Gioia, L., Grieco, F. V., de Lucia, C., Komici, K., Corbi, G., Edison, P., et al. (2017) · Journal of Diabetes Research · doi:10.1155/2017/7420796 · Cited by 56 · see citing works

Probucol prevents blood–brain barrier dysfunction and cognitive decline in mice maintained on pro-diabetic diet

Mamo, J. C. L., Lam, V., Brook, E., Mooranian, A., Al‐Salami, H., Fimognari, N., Nesbit, M., & Takechi, R. (2018) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118795274 · Cited by 56 · see citing works

Xanthoceraside attenuates learning and memory deficits via improving insulin signaling in STZ-induced AD rats

Liu, P., Zou, L., Jiao, Q., Chi, T., Ji, X., Qi, Y. A., Xu, Q., & Wang, L. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.02.065 · Cited by 55 · see citing works

Brain insulin resistance and the therapeutic value of insulin and insulin-sensitizing drugs in Alzheimer’s disease neuropathology

Yang, J. J. (2022) · Acta Neurologica Belgica · doi:10.1007/s13760-022-01907-2 · Cited by 21 · see citing works

Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer’s Disease Treatment

Poor, S. R., Ettcheto, M., Cano, A. C., Sánchez‐López, E., Manzine, P. R., Olloquequi, J., Camins, A., & Javan, M. (2021) · Pharmaceuticals · doi:10.3390/ph14090890 · Cited by 40 · see citing works

Behavioural and neuropathological effects of intranasal insulin treatment in a triple-transgenic mouse model of Alzheimer's disease (3xTg-AD)

Silvio, C., Barone, E., Lavecchia, A. M., Martina, L., Annachiara, M., Marzia Perluigi, A., & Cassano, T. (2017) · IRIS Research product catalog (Sapienza University of Rome)

Insulin mediated novel therapies for the treatment of Alzheimer's disease

Dubey, S. K., Lakshmi, K. K., Krishna, K. V., Agrawal, M., Singhvi, G., Saha, R. N., Saraf, S., Saraf, S., Shukla, R., & Alexander, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117540 · Cited by 60 · see citing works

Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: Relevance to Alzheimer's disease

de la Monte, S. M., Tong, M., Lester-Coll, N. H., Plater, M. E., & Wands, J. R. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-10113 · Cited by 324 · see citing works